Our immunostaining results also indicated that TEM1 expression was significantly higher in hypertrophic scars and keloids than in normal skin, as well as being associated with fibroblast activation markers such as α-SMA, COL1A1, and FN1 (Fig. 1A). The gene discussed is FN1; the disease is keloid.